Dive in

We have our own point of view on the people, technologies, and conversations that will shape the future.

Tag results
Tech Enabled Bio
Clear all
List view Grid view
Filters
Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference​

For those in healthcare, JPM provides the unofficial kickoff to every new year with a chance to recap the year before and inform our view on the year ahead.

February 13, 2024Greg Yap, Johnny Hu and Ph.D.
Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines

Predictive and generative AI are entering many new applications. At Menlo Ventures, we are especially excited about applications for AI in drug discovery and development, specifically when new technology can directly address a major unmet need.

September 15, 2023Johnny Hu, Ph.D. and Greg Yap
Opportunities and Challenges of Applying Generative AI to Designing New Drugs

Drug design is both a natural fit and a unique challenge for generative AI, given large but messy datasets, time and cost of real-world testing, and the complexity of human trials.

August 9, 2023Johnny Hu and Ph.D.
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics

Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.

May 2, 2023Greg Yap
Video: Early Cancer Detection With Delfi

Delfi Diagnostics has developed a test that combines ultra-low-cost sequencing and machine learning to detect cancer early.

March 9, 2023Greg Yap
Video: Reengineering Drug Discovery With Recursion

Recursion is a breakthrough drug discovery company that combines a novel computer vision platform with deep disease biology and chemistry.

March 9, 2023Greg Yap, Johnny Hu and Ph.D.
loader.svg